Commercio PBYI

Puma Biotechnology Inc

-

00:00:00

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company’s drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Leggi tutto...

PBYI
Specifiche commerciali

Cifre

3

Punto

0.001

Diffusione

floating

Dimensioni del contratto

1

Volume Min

1

Volume massimo

10,000

Volume Step

1

Scambio lungo (punti)

-0.610

Scambio breve (punti)

-0.360
Disponibile su
MT5, TV, cTrader
Ultimo aggiornamento a Gennaio 24, 21:09 GMT+3
*Fonte dei dati: Prezzi del conto MT5 Server Prime

PBYI
Calendario economico

Non sono stati trovati dati

Cambiamento 1D

1.003%

PerchƩ BlackBull Mercati?

26k+

AttivitĆ  negoziabili

1:500

Leva fino a

Regolamentato

Multiregolamentato

24/7

Assistenza clienti

$0

Nessun deposito minimo

Calcolatore del margine

Calculation Results

Current Price

2.95

Required Margin

Converted Currency

Required Margin

Account Base Currency

Calcolatore di profitti e perdite

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Calcolatore di swap

Calculation Results

2.95

OpportunitĆ  di trading

Non sono stati trovati dati
Join Now